logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On January 13th, HSBC Holdings (00005) spent 54.84 million pounds to buy back 690.85 million shares.

date
17:25 14/01/2025
avatar
GMT Eight
HSBC Holdings (00005) announces that on January 13, 2025, the company spent 54... on the London Stock Exchange.
HSBC Holdings (00005) announced that on January 13, 2025, the company repurchased 6.9085 million shares on the London Stock Exchange at a cost of 54.8487 million. On the same day, the company repurchased 2.05 million shares on the Hong Kong Stock Exchange at a cost of HK$207 million.
Related Articles
HK Stock
REMEGEN (09995): Wang Weidong re-elected as Chairman of the Board of Directors.
HK Stock
LYUE PHARMA (02186) innovative drug LY03015 (VMAT2 inhibitor/Sigma-1R agonist) has achieved positive results in the Phase II clinical trial for the treatment of delayed onset movement disorders in China.
US Stock Market Move | Qualcomm (QCOM.US) opens up more than 4%, rumored to be in talks to acquire Tenstorrent.
REMEGEN (09995): Wang Weidong re-elected as Chairman of the Board of Directors.
HK Stock
LYUE PHARMA (02186) innovative drug LY03015 (VMAT2 inhibitor/Sigma-1R agonist) has achieved positive results in the Phase II clinical trial for the treatment of delayed onset movement disorders in China.
HK Stock
US Stock Market Move | Qualcomm (QCOM.US) opens up more than 4%, rumored to be in talks to acquire Tenstorrent.
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.